Market Cap: $10.96B
RC
Repligen Corporation
RGEN
NASDAQ (NASDAQ Global Select)USD
Market Cap: $10.96B
Repligen Corporation enhances its commitment to bioprocessing innovation with the opening of its new Training & Innovation Center at the OPUS pre-packed chromatography column manufacturing site in Bre…
Repligen Corporation: Navigating the Future of Bioprocessing Solutions Repligen Corporation stands at a pivotal juncture in the evolving biopharmaceutical landscape, highlighted by recent analyst rati…
Repligen's Steady Ascent Amid Mixed Analyst Sentiment Repligen Corporation is a key player in the bioprocessing solutions sector, and the company's innovative technologies continue to draw attention a…
### Repligen's Strategic Positioning in Bioprocessing: Analyst Insights Repligen Corporation, a leader in bioprocessing technologies, currently attracts attention from market analysts as it continues…
Repligen's Insider Activity: Implications for the Bioprocessing Sector On November 19, James Bylund, Chief Operating Officer of Repligen Corporation, executes a significant insider sale, prompting dis…
Repligen Corporation Faces Scrutiny Following Insider Sale Repligen Corporation, a key player in the bioprocessing industry that supports the production of biologic drugs, finds itself in the spotligh…
Bruker’s Upcoming Earnings Report: Implications for the Scientific Instrumentation Sector Bruker Corporation, a key player in the scientific instrumentation market, prepares to release its quarterly e…
Repligen's Focus on Innovation and Growth in Bioprocessing Repligen, a leader in bioprocessing technologies, continues to emphasize innovation and expansion in its product offerings to meet the growin…
Repligen Expands Bioprocessing Capabilities with New Technology Acquisition Repligen Corporation, a leading provider of bioprocessing technologies, enhances its operational capacity through the recent…
Repligen Expands Its Bioprocessing Capabilities with New Facilities Repligen Corporation, a leader in bioprocessing technology, announces the opening of its new state-of-the-art manufacturing facility…
Repligen's Strategic Position in a Dynamic Bioprocessing Landscape Repligen Corporation, a key player in the biopharmaceutical sector, finds itself at a crossroads as analysts weigh in on its future p…
Repligen Corporation: Navigating Opportunities in Bioprocessing Amidst Analyst Divergence Repligen Corporation emerges as a significant player in the bioprocessing sector, leveraging its innovative so…
Repligen Corporation: Navigating a Complex Biopharmaceutical Landscape Repligen Corporation stands at a pivotal juncture in the biopharmaceutical industry, marked by varying analyst perspectives on it…
Repligen Corporation: Navigating Diverse Analyst Perspectives in Bioprocessing In the dynamic landscape of bioprocessing, Repligen Corporation (RGEN) finds itself under the scrutiny of six analysts wh…
Repligen's Market Position: A Complex Landscape of Analyst Insights Repligen Corporation, a leader in the bioprocessing sector, currently navigates a multifaceted market landscape as six analysts rece…
Repligen Corporation's Market Position Under Review Amid Diverse Analyst Opinions In recent months, Repligen Corporation (RGEN) garners attention as six analysts provide a range of insights into its p…
Repligen Faces Prolonged Challenges in Bioprocessing Sector Repligen Corporation (RGEN), a key player in the bioprocessing industry, currently navigates significant operational challenges that could i…
Repligen Faces Prolonged Challenges Amid Market Concerns Repligen Corporation, a key player in the bioprocessing industry, is currently navigating significant hurdles that have persisted for over 1,40…
Repligen Corporation: Navigating Analyst Sentiments in Bioprocessing Repligen Corporation, a key player in the bioprocessing sector, currently faces a diverse array of opinions from six analysts regar…
Repligen Corporation: Navigating Analyst Perspectives in Bioprocessing Repligen Corporation, a leader in the bioprocessing sector, finds itself under the scrutiny of six analysts who recently shared t…
Diverse Analyst Perspectives Highlight Repligen’s Bioprocessing Landscape Repligen Corporation (RGEN), a key player in the bioprocessing industry, finds itself at the center of varied analyst evaluati…
Repligen's Market Position and Analyst Perspectives: A Closer Look In recent months, analysts have cast a spotlight on Repligen Corporation, a key player in the bioprocessing sector, revealing a spect…
Repligen Corporation: Navigating a Complex Bioprocessing Landscape In the rapidly evolving bioprocessing industry, Repligen Corporation (RGEN) stands out with its innovative solutions and strong marke…
Repligen Corporation: Navigating a Complex Bioprocessing Landscape Repligen Corporation stands at the forefront of the bioprocessing industry, where it plays a pivotal role in developing technologies…
Repligen’s Role in Bioprocessing: Enhancing Efficiency in Biopharmaceutical Production Repligen is making significant strides in the bioprocessing industry, particularly in the production of biopharma…